ETHEPHON - परिणामों की खोज

यूरोपीय संघ - हंगेरियाई - EMA (European Medicines Agency)

beyfortus

astrazeneca ab - nirsevimab - immunrendszer sera, immunglobulinok, - beyfortus is indicated for the prevention of respiratory syncytial virus (rsv) lower respiratory tract disease in neonates and infants during their first rsv season. beyfortus should be used in accordance with official recommendations.

यूरोपीय संघ - हंगेरियाई - EMA (European Medicines Agency)

bekemv

amgen technology (ireland) uc - ekulizumab - hemoglobinuria, paroxysmal - immunszuppresszánsok - bekemv is indicated in adults and children for the treatment of paroxysmal nocturnal haemoglobinuria (pnh). bizonyíték a klinikai haszon kimutatható a betegek hemolízis klinikai tünet(ek) jelzi, hogy a magas betegség tevékenység, függetlenül attól, transzfúzió történelem (lásd 5.

यूरोपीय संघ - हंगेरियाई - EMA (European Medicines Agency)

tyruko

sandoz gmbh - natalizumabot - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunszuppresszánsok - tyruko is indicated as single disease modifying therapy in adults with highly active relapsing remitting multiple sclerosis (rrms) for the following patient groups: patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (dmt) (for exceptions and information about washout periods see sections 4. 4 és 5. 1), or, patients with rapidly evolving severe rrms defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain magnetic resonance imaging (mri) or a significant increase in t2 lesion load as compared to a previous recent mri.